Latest Period
Q2 2026
Security Snapshot
ANAVEX LIFE SCIENCES CORP. - Common Stock (AVXL) Institutional Ownership
CUSIP: 032797300
13F Institutional Holders and Ownership History from Q4 2015 to Q2 2026
Institutions Reporting
175
Shares (Excl. Options)
36,957,032
Price
$2.59
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- AVXL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 36,957,032
- Total 13F value
- $95,815,588
- Portfolio coverage rank
- 0%
- Share change
- -3,012,841
- Value change
- -$8,982,287
- Number of holders
- 175
- Shares outstanding
- 92,712,903
- SEC-reported price per share
- $2.48
- Insider filing price
- $2.48
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AVXL - ANAVEX LIFE SCIENCES CORP. - Common Stock is tracked under CUSIP 032797300.
- 175 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 186 to 175 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $122,707,841 to $95,815,588.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 175 institutions filings for Q2 2026.
Security key
032797300
Latest holder period
Q2 2026
13F holders
175
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
AVXL full holder history
ANAVEX LIFE SCIENCES CORP. SEC filings
ANAVEX LIFE SCIENCES CORP. company facts
ANAVEX LIFE SCIENCES CORP. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 032797300:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
AVXL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $11,658,648 | 4,663,459 | Vanguard Capital Management | 30 Jun 2026 |
As of 30 Jun 2026, 175 institutional investors reported holding 36,957,032 shares of ANAVEX LIFE SCIENCES CORP. - Common Stock (AVXL). This represents 40% of the company’s total 92,712,903 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
35%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.7% | 8,055,628 | +5.9% | 0% | $20,864,076 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 4,054,589 | +4.9% | 0% | $10,501,386 |
| TWO SIGMA INVESTMENTS, LP | 3.3% | 3,046,538 | -6.2% | 0.01% | $7,890,533 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 2,407,473 | +10% | 0% | $6,236,854 |
| STATE STREET CORP | 2.1% | 1,922,770 | -57% | 0% | $4,979,974 |
| FEDERATED HERMES, INC. | 1.2% | 1,071,809 | +101% | 0% | $2,775,985 |
| AQR CAPITAL MANAGEMENT LLC | 1% | 963,014 | +27% | 0% | $2,494,204 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1% | 948,633 | +21% | 0% | $2,456,959 |
| Summit Financial, LLC | 0.98% | 909,430 | -3.3% | 0.03% | $2,355,422 |
| GOLDMAN SACHS GROUP INC | 0.96% | 890,634 | +11% | 0% | $2,306,742 |
| MARSHALL WACE, LLP | 0.96% | 889,523 | +112% | 0% | $2,303,865 |
| NORTHERN TRUST CORP | 0.85% | 784,494 | +8.2% | 0% | $2,031,839 |
| BARCLAYS PLC | 0.81% | 754,226 | +40% | 0% | $1,953,447 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 734,795 | -2.9% | 0% | $1,903,119 |
| BANK OF AMERICA CORP /DE/ | 0.71% | 654,295 | -24% | 0% | $1,694,624 |
| VANGUARD FIDUCIARY TRUST CO | 0.67% | 621,451 | -4% | 0% | $1,609,558 |
| UBS Group AG | 0.67% | 620,374 | +8.8% | 0% | $1,606,769 |
| Private Advisor Group, LLC | 0.54% | 504,000 | +0.86% | 0.01% | $1,305,360 |
| LPL Financial LLC | 0.44% | 406,109 | -3% | 0% | $1,051,822 |
| STIFEL FINANCIAL CORP | 0.36% | 332,597 | +40% | 0% | $861,429 |
| CITADEL ADVISORS LLC | 0.35% | 329,115 | -41% | 0% | $852,408 |
| PVG ASSET MANAGEMENT CORP | 0.35% | 327,344 | -0.06% | 0.49% | $847,821 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.34% | 319,529 | -68% | 0% | $827,580 |
| Bank of New York Mellon Corp | 0.31% | 288,199 | +16% | 0% | $746,435 |
| Apella Capital, LLC | 0.25% | 227,995 | +49% | 0.01% | $617,866 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
43
Latest
Q2 2026
Rows shown
1-25 of 43
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 36,957,032 | $95,815,588 | -$8,982,287 | $2.59 | 175 |
| 2026 Q1 | 39,988,887 | $122,707,841 | +$2,540,790 | $3.07 | 186 |
| 2025 Q4 | 37,790,002 | $135,892,694 | +$14,995,766 | $3.56 | 180 |
| 2025 Q3 | 32,468,725 | $289,473,061 | -$273,984 | $8.90 | 184 |
| 2025 Q2 | 32,493,276 | $301,726,227 | +$10,099,066 | $9.22 | 175 |
| 2025 Q1 | 31,369,737 | $269,176,514 | +$13,007,772 | $8.58 | 178 |
| 2024 Q4 | 29,547,094 | $316,161,065 | +$29,473,787 | $10.74 | 167 |
| 2024 Q3 | 26,968,911 | $153,149,572 | -$533,003 | $5.68 | 142 |
| 2024 Q2 | 26,760,101 | $112,930,616 | -$18,825,367 | $4.22 | 135 |
| 2024 Q1 | 30,948,610 | $157,506,940 | +$27,304,520 | $5.09 | 140 |
| 2023 Q4 | 25,832,104 | $240,513,953 | +$8,316,479 | $9.31 | 146 |
| 2023 Q3 | 25,058,666 | $164,128,831 | -$1,892,057 | $6.55 | 140 |
| 2023 Q2 | 25,281,347 | $205,636,828 | -$14,163,807 | $8.13 | 143 |
| 2023 Q1 | 27,108,237 | $232,269,844 | +$393,430 | $8.57 | 139 |
| 2022 Q4 | 27,002,000 | $250,064,092 | +$22,831,014 | $9.26 | 136 |
| 2022 Q3 | 24,372,403 | $251,469,999 | -$6,293,663 | $10.32 | 139 |
| 2022 Q2 | 24,888,142 | $249,199,961 | -$1,729,547 | $10.01 | 142 |
| 2022 Q1 | 24,991,414 | $307,685,297 | +$32,689,444 | $12.31 | 131 |
| 2021 Q4 | 22,100,211 | $383,138,229 | +$25,372,466 | $17.34 | 142 |
| 2021 Q3 | 20,580,263 | $369,399,670 | -$25,050,093 | $17.95 | 131 |
| 2021 Q2 | 21,526,442 | $492,165,210 | +$81,312,363 | $22.86 | 124 |
| 2021 Q1 | 18,187,562 | $271,803,006 | +$79,133,906 | $14.95 | 101 |
| 2020 Q4 | 13,964,886 | $75,410,516 | +$6,571,033 | $5.40 | 88 |
| 2020 Q3 | 12,684,452 | $57,699,630 | +$3,160,613 | $4.55 | 75 |
| 2020 Q2 | 11,946,714 | $58,843,561 | +$1,942,364 | $4.92 | 74 |